---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-24-002130"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:10:30.512178+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Lipella Pharma special meeting adjourned due to lack of quorum; reconvenes Dec 27

## Summary
- Special meeting on Dec 20, 2024 lacked a quorum; adjourned to Dec 27, 2024 at 2:00 p.m. ET.
- Valid proxies submitted before original meeting remain valid for reconvened meeting unless revoked.
- No proposals were voted on; meeting was virtual.
- Company filed definitive proxy statement on Nov 12, 2024 for the special meeting.

## SEC filing metadata
- accession: 0001753926-24-002130
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392624002130/0001753926-24-002130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392624002130/g084611_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-24-002130
- JSON: https://secwatch.observer/filing/0001753926-24-002130.json
- Plain text: https://secwatch.observer/filing/0001753926-24-002130.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.